Enzyme-based products
The company uses its proprietary technology platform to support a broad product pipeline.
Source: LinkedIn company description · Retrieved October 13, 2026
Alcresta Therapeutics develops and commercializes enzyme-based products for people living with gastrointestinal disorders and rare diseases.
The company is based in Massachusetts. Its product pipeline initially focuses on pancreatic insufficiency or fat malabsorption associated with cystic fibrosis, digestive cancers, preterm birth, and other serious diseases.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company’s lead product is indicated for pediatric patients, including neonates and infants, and adults.
The company uses its proprietary technology platform to support a broad product pipeline.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026, September 18, 2026, September 28, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.